-
1
-
-
0028883828
-
Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia
-
COI: 1:CAS:528:DyaK28Xhslemsw%3D%3D, PID: 7566020
-
Shepherd J, Cobbe SM, Ford I, Isles CG, Lorimer AR, MacFarlane PW, McKillop JH, Packard CJ, the West of Scotland Coronary Prevention Study Group. Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. N Engl J Med. 1995;333:1301–7.
-
(1995)
N Engl J Med
, vol.333
, pp. 1301-1307
-
-
Shepherd, J.1
Cobbe, S.M.2
Ford, I.3
Isles, C.G.4
Lorimer, A.R.5
MacFarlane, P.W.6
McKillop, J.H.7
Packard, C.J.8
-
2
-
-
33748952489
-
Primary prevention of cardiovascular disease with pravastatin in Japan (MEGA study): a prospective randomised controlled trial
-
COI: 1:CAS:528:DC%2BD28XhtVWqtb7K, PID: 17011942
-
Nakamura H, Arakawa K, Itakura H, Kitabatake A, Goto Y, Toyota T, Nakaya N, Nishimoto S, Muranaka M, Yamamoto A, Mizuno K, Ohashi Y, the MEGA Study Group. Primary prevention of cardiovascular disease with pravastatin in Japan (MEGA study): a prospective randomised controlled trial. Lancet. 2006;368:1155–63.
-
(2006)
Lancet
, vol.368
, pp. 1155-1163
-
-
Nakamura, H.1
Arakawa, K.2
Itakura, H.3
Kitabatake, A.4
Goto, Y.5
Toyota, T.6
Nakaya, N.7
Nishimoto, S.8
Muranaka, M.9
Yamamoto, A.10
Mizuno, K.11
Ohashi, Y.12
-
3
-
-
0027987849
-
Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S)
-
Scandinavian Simvastatin Survival Study Group. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S). Lancet. 1994;344:1383–9.
-
(1994)
Lancet
, vol.344
, pp. 1383-1389
-
-
-
4
-
-
0342981862
-
The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels
-
COI: 1:CAS:528:DyaK28XmsFWls7c%3D, PID: 8801446
-
Sacks FM, Pfeffer MA, Moye LA, Rouleau JL, Rutherford JD, Cole TG, Brown L, Warnica JW, Arnold JM, Wun CC, Davis BR, Braunwald E, the Cholesterol and Recurrent Events Trial Investigators. The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. N Engl J Med. 1996;335:1001–9.
-
(1996)
N Engl J Med
, vol.335
, pp. 1001-1009
-
-
Sacks, F.M.1
Pfeffer, M.A.2
Moye, L.A.3
Rouleau, J.L.4
Rutherford, J.D.5
Cole, T.G.6
Brown, L.7
Warnica, J.W.8
Arnold, J.M.9
Wun, C.C.10
Davis, B.R.11
Braunwald, E.12
-
5
-
-
26844564725
-
The potential relevance of the multiple lipid-independent (pleiotropic) effects of statins in the management of acute coronary syndromes
-
COI: 1:CAS:528:DC%2BD2MXhtFWht7zE, PID: 16226165
-
Ray KK, Cannon CP. The potential relevance of the multiple lipid-independent (pleiotropic) effects of statins in the management of acute coronary syndromes. J Am Coll Cardiol. 2005;46:1425–33.
-
(2005)
J Am Coll Cardiol
, vol.46
, pp. 1425-1433
-
-
Ray, K.K.1
Cannon, C.P.2
-
6
-
-
77951716673
-
Statin therapy—part I: the pleiotropic effects of statins in cardiovascular disease
-
Sadowitz B, Maier KG, Gahtan V. Statin therapy—part I: the pleiotropic effects of statins in cardiovascular disease. Vasc Endovasc Surg. 2010;44:241–51.
-
(2010)
Vasc Endovasc Surg
, vol.44
, pp. 241-251
-
-
Sadowitz, B.1
Maier, K.G.2
Gahtan, V.3
-
7
-
-
84906791819
-
Cardiovascular effects of statins, beyond the lipid-lowering properties
-
COI: 1:CAS:528:DC%2BC2cXkslehtbw%3D, PID: 24631782
-
Mihos CG, Pineda AM, Santana O. Cardiovascular effects of statins, beyond the lipid-lowering properties. Pharmacol Res. 2014;88:12–9.
-
(2014)
Pharmacol Res
, vol.88
, pp. 12-19
-
-
Mihos, C.G.1
Pineda, A.M.2
Santana, O.3
-
8
-
-
0035963529
-
Measurement of C-reactive protein for the targeting of statin therapy in the primary prevention of acute coronary events
-
COI: 1:CAS:528:DC%2BD3MXltFersrc%3D, PID: 11430324
-
Ridker PM, Rifai N, Clearfield M, Downs JR, Weis SE, Miles JS, Gotto AM Jr, the Air Force/Texas Coronary Atherosclerosis Prevention Study Investigators. Measurement of C-reactive protein for the targeting of statin therapy in the primary prevention of acute coronary events. N Engl J Med. 2001;344:1959–65.
-
(2001)
N Engl J Med
, vol.344
, pp. 1959-1965
-
-
Ridker, P.M.1
Rifai, N.2
Clearfield, M.3
Downs, J.R.4
Weis, S.E.5
Miles, J.S.6
Gotto, A.M.7
-
9
-
-
84912100863
-
Statins in oncological research: from experimental studies to clinical practice
-
PID: 25220658
-
Kubatka P, Kruzliak P, Rotrekl V, Jelinkova S, Mladosievicova B. Statins in oncological research: from experimental studies to clinical practice. Crit Rev Oncol Hematol. 2014;92:296–311.
-
(2014)
Crit Rev Oncol Hematol
, vol.92
, pp. 296-311
-
-
Kubatka, P.1
Kruzliak, P.2
Rotrekl, V.3
Jelinkova, S.4
Mladosievicova, B.5
-
10
-
-
84937641883
-
Statin use and mortality in cancer patients: systematic review and meta-analysis of observational studies
-
COI: 1:CAS:528:DC%2BC2MXmsVersrw%3D, PID: 25890842
-
Zhong S, Zhang X, Chen L, Ma T, Tang J, Zhao J. Statin use and mortality in cancer patients: systematic review and meta-analysis of observational studies. Cancer Treat Rev. 2015;41:554–67.
-
(2015)
Cancer Treat Rev
, vol.41
, pp. 554-567
-
-
Zhong, S.1
Zhang, X.2
Chen, L.3
Ma, T.4
Tang, J.5
Zhao, J.6
-
11
-
-
26244441019
-
The effect of prior statin use on 30-day mortality for patients hospitalized with community-acquired pneumonia
-
Mortensen EM, Restrepo MI, Anzueto A, Pugh J. The effect of prior statin use on 30-day mortality for patients hospitalized with community-acquired pneumonia. Resp Res. 2005;6:82.
-
(2005)
Resp Res
, vol.6
, pp. 82
-
-
Mortensen, E.M.1
Restrepo, M.I.2
Anzueto, A.3
Pugh, J.4
-
12
-
-
54949095097
-
Preadmission use of statins and outcomes after hospitalization with pneumonia: population-based cohort study of 29,900 patients
-
PID: 18955636
-
Thomsen RW, Riis A, Kornum JB, Christensen S, Johnsen SP, Sørensen HT. Preadmission use of statins and outcomes after hospitalization with pneumonia: population-based cohort study of 29,900 patients. Arch Intern Med. 2008;168:2081–7.
-
(2008)
Arch Intern Med
, vol.168
, pp. 2081-2087
-
-
Thomsen, R.W.1
Riis, A.2
Kornum, J.B.3
Christensen, S.4
Johnsen, S.P.5
Sørensen, H.T.6
-
13
-
-
84906791607
-
Statins, bone metabolism and treatment of bone catabolic diseases
-
COI: 1:CAS:528:DC%2BC2cXhtlKhu7Y%3D, PID: 24407282
-
Zhang Y, Bradley AD, Wang D, Reinhardt RA. Statins, bone metabolism and treatment of bone catabolic diseases. Pharmacol Res. 2014;88:53–61.
-
(2014)
Pharmacol Res
, vol.88
, pp. 53-61
-
-
Zhang, Y.1
Bradley, A.D.2
Wang, D.3
Reinhardt, R.A.4
-
14
-
-
79955591911
-
Statin use associates with a lower incidence of acute kidney injury after major elective surgery
-
PID: 21493769
-
Molnar AO, Coca SG, Devereaux PJ, Jain AK, Kitchlu A, Luo J, Parikh CR, Paterson JM, Siddiqui N, Wald R, Walsh M, Garg AX. Statin use associates with a lower incidence of acute kidney injury after major elective surgery. J Am Soc Nephrol. 2011;22:939–46.
-
(2011)
J Am Soc Nephrol
, vol.22
, pp. 939-946
-
-
Molnar, A.O.1
Coca, S.G.2
Devereaux, P.J.3
Jain, A.K.4
Kitchlu, A.5
Luo, J.6
Parikh, C.R.7
Paterson, J.M.8
Siddiqui, N.9
Wald, R.10
Walsh, M.11
Garg, A.X.12
-
15
-
-
56749158839
-
Statin use is associated with early recovery of kidney injury after vascular surgery and improved long-term outcome
-
COI: 1:CAS:528:DC%2BD1cXhsVWlsrrJ, PID: 18628367
-
Welten GM, Chonchol M, Schouten O, Hoeks S, Bax JJ, van Domburg RT, van Sambeek M, Poldermans D. Statin use is associated with early recovery of kidney injury after vascular surgery and improved long-term outcome. Nephrol Dial Transplant. 2008;23:3867–73.
-
(2008)
Nephrol Dial Transplant
, vol.23
, pp. 3867-3873
-
-
Welten, G.M.1
Chonchol, M.2
Schouten, O.3
Hoeks, S.4
Bax, J.J.5
van Domburg, R.T.6
van Sambeek, M.7
Poldermans, D.8
-
16
-
-
84871287126
-
Impact of a high loading dose of atorvastatin on contrast-induced acute kidney injury
-
COI: 1:CAS:528:DC%2BC38XhvVCqsLrP, PID: 23147173
-
Quintavalle C, Fiore D, De Micco F, Visconti G, Focaccio A, Golia B, Ricciardelli B, Donnarumma E, Bianco A, Zabatta MA, Troncone G, Colombo A, Briguori C, Condorelli G. Impact of a high loading dose of atorvastatin on contrast-induced acute kidney injury. Circulation. 2012;126:3008–16.
-
(2012)
Circulation
, vol.126
, pp. 3008-3016
-
-
Quintavalle, C.1
Fiore, D.2
De Micco, F.3
Visconti, G.4
Focaccio, A.5
Golia, B.6
Ricciardelli, B.7
Donnarumma, E.8
Bianco, A.9
Zabatta, M.A.10
Troncone, G.11
Colombo, A.12
Briguori, C.13
Condorelli, G.14
-
17
-
-
84884213500
-
Effect of statin use on acute kidney injury risk following coronary artery bypass grafting
-
COI: 1:CAS:528:DC%2BC3sXhs1Witg%3D%3D, PID: 23273532
-
Layton JB, Kshirsagar AV, Simpson RJ Jr, Pate V, Funk MJ, Stürmer T, Brookhart MA. Effect of statin use on acute kidney injury risk following coronary artery bypass grafting. Am J Cardiol. 2013;111:823–8.
-
(2013)
Am J Cardiol
, vol.111
, pp. 823-828
-
-
Layton, J.B.1
Kshirsagar, A.V.2
Simpson, R.J.3
Pate, V.4
Funk, M.J.5
Stürmer, T.6
Brookhart, M.A.7
-
18
-
-
84937734258
-
Preoperative statin therapy and renal outcomes after cardiac surgery: a meta-analysis and meta-regression of 59,771 patients
-
PID: 26081692
-
Wang J, Gu C, Gao M, Yu W, Yu Y. Preoperative statin therapy and renal outcomes after cardiac surgery: a meta-analysis and meta-regression of 59,771 patients. Can J Cardiol. 2015;31:1051–60.
-
(2015)
Can J Cardiol
, vol.31
, pp. 1051-1060
-
-
Wang, J.1
Gu, C.2
Gao, M.3
Yu, W.4
Yu, Y.5
-
19
-
-
34249685010
-
Mevalonate pathway: a review of clinical and therapeutical implications
-
COI: 1:CAS:528:DC%2BD2sXmtVGrs7w%3D, PID: 17467679
-
Buhaescu I, Izzedine H. Mevalonate pathway: a review of clinical and therapeutical implications. Clin Biochem. 2007;40:575–84.
-
(2007)
Clin Biochem
, vol.40
, pp. 575-584
-
-
Buhaescu, I.1
Izzedine, H.2
-
20
-
-
0027490174
-
SREBP-1, a basic-helix-loop-helix-leucine zipper protein that controls transcription of the low density lipoprotein receptor gene
-
COI: 1:CAS:528:DyaK2cXkslajuw%3D%3D, PID: 8402897
-
Yokoyama C, Wang X, Briggs MR, Admon A, Wu J, Hua X, Goldstein JL, Brown MS. SREBP-1, a basic-helix-loop-helix-leucine zipper protein that controls transcription of the low density lipoprotein receptor gene. Cell. 1993;75:187–97.
-
(1993)
Cell
, vol.75
, pp. 187-197
-
-
Yokoyama, C.1
Wang, X.2
Briggs, M.R.3
Admon, A.4
Wu, J.5
Hua, X.6
Goldstein, J.L.7
Brown, M.S.8
-
21
-
-
0028225462
-
SREBP-1, a membrane-bound transcription factor released by sterol-regulated proteolysis
-
COI: 1:CAS:528:DyaK2cXis1KmsLw%3D, PID: 8156598
-
Wang X, Sato R, Brown MS, Hua X, Goldstein JL. SREBP-1, a membrane-bound transcription factor released by sterol-regulated proteolysis. Cell. 1994;77:53–62.
-
(1994)
Cell
, vol.77
, pp. 53-62
-
-
Wang, X.1
Sato, R.2
Brown, M.S.3
Hua, X.4
Goldstein, J.L.5
-
22
-
-
84931411520
-
Ezetimibe added to statin therapy after acute coronary syndromes
-
COI: 1:CAS:528:DC%2BC2MXhtFyrtbbF, PID: 26039521
-
Cannon CP, Blazing MA, Giugliano RP, McCagg A, White JA, Theroux P, Darius H, Lewis BS, Ophuis TO, Jukema JW, De Ferrari GM, Ruzyllo W, De Lucca P, Im K, Bohula EA, Reist C, Wiviott SD, Tershakovec AM, Musliner TA, Braunwald E, Califf RM, IMPROVE-IT Investigators. Ezetimibe added to statin therapy after acute coronary syndromes. N Engl J Med. 2015;372:2387–97.
-
(2015)
N Engl J Med
, vol.372
, pp. 2387-2397
-
-
Cannon, C.P.1
Blazing, M.A.2
Giugliano, R.P.3
McCagg, A.4
White, J.A.5
Theroux, P.6
Darius, H.7
Lewis, B.S.8
Ophuis, T.O.9
Jukema, J.W.10
De Ferrari, G.M.11
Ruzyllo, W.12
De Lucca, P.13
Im, K.14
Bohula, E.A.15
Reist, C.16
Wiviott, S.D.17
Tershakovec, A.M.18
Musliner, T.A.19
Braunwald, E.20
Califf, R.M.21
more..
-
23
-
-
0032554676
-
Influence of pravastatin and plasma lipids on clinical events in the West of Scotland Coronary Prevention Study (WOSCOPS)
-
West of Scotland Coronary Prevention Study Group. Influence of pravastatin and plasma lipids on clinical events in the West of Scotland Coronary Prevention Study (WOSCOPS). Circulation. 1998;97:1440–5.
-
(1998)
Circulation
, vol.97
, pp. 1440-1445
-
-
-
24
-
-
70749119012
-
Meta-analysis of randomized controlled trials of statins versus placebo in patients with heart failure
-
COI: 1:CAS:528:DC%2BD1MXhsFagsbjF, PID: 19962481
-
Lipinski MJ, Cauthen CA, Biondi-Zoccai GG, Abbate A, Vrtovec B, Khan BV, Vetrovec GW. Meta-analysis of randomized controlled trials of statins versus placebo in patients with heart failure. Am J Cardiol. 2009;104:1708–16.
-
(2009)
Am J Cardiol
, vol.104
, pp. 1708-1716
-
-
Lipinski, M.J.1
Cauthen, C.A.2
Biondi-Zoccai, G.G.3
Abbate, A.4
Vrtovec, B.5
Khan, B.V.6
Vetrovec, G.W.7
-
25
-
-
1042268126
-
Statins induce the regression of left ventricular mass in patients with angina
-
COI: 1:CAS:528:DC%2BD2cXhsVGhsb0%3D, PID: 14745145
-
Nishikawa H, Miura S, Zhang B, Shimomura H, Arai H, Tsuchiya Y, Matsuo K, Saku K. Statins induce the regression of left ventricular mass in patients with angina. Circ J. 2004;68:121–5.
-
(2004)
Circ J
, vol.68
, pp. 121-125
-
-
Nishikawa, H.1
Miura, S.2
Zhang, B.3
Shimomura, H.4
Arai, H.5
Tsuchiya, Y.6
Matsuo, K.7
Saku, K.8
-
26
-
-
39149142513
-
Antiarrhythmic effect of statin therapy and atrial fibrillation: a meta-analysis of randomized controlled trials
-
COI: 1:CAS:528:DC%2BD1cXitlequ7k%3D, PID: 18294568
-
Fauchier L, Pierre B, de Labriolle A, Grimard C, Zannad N, Babuty D. Antiarrhythmic effect of statin therapy and atrial fibrillation: a meta-analysis of randomized controlled trials. J Am Coll Cardiol. 2008;51:828–35.
-
(2008)
J Am Coll Cardiol
, vol.51
, pp. 828-835
-
-
Fauchier, L.1
Pierre, B.2
de Labriolle, A.3
Grimard, C.4
Zannad, N.5
Babuty, D.6
-
27
-
-
0035186999
-
Statins as antioxidant therapy for preventing cardiac myocyte hypertrophy
-
COI: 1:CAS:528:DC%2BD3MXosVyrur4%3D, PID: 11714734
-
Takemoto M, Node K, Nakagami H, Liao Y, Grimm M, Takemoto Y, Kitakaze M, Liao JK. Statins as antioxidant therapy for preventing cardiac myocyte hypertrophy. J Clin Invest. 2001;108:1429–37.
-
(2001)
J Clin Invest
, vol.108
, pp. 1429-1437
-
-
Takemoto, M.1
Node, K.2
Nakagami, H.3
Liao, Y.4
Grimm, M.5
Takemoto, Y.6
Kitakaze, M.7
Liao, J.K.8
-
28
-
-
0036162113
-
Cellular antioxidant effects of atorvastatin in vitro and in vivo
-
COI: 1:CAS:528:DC%2BD38Xhtlyjsbg%3D, PID: 11834532
-
Wassmann S, Laufs U, Müller K, Konkol C, Ahlbory K, Bäumer AT, Linz W, Böhm M, Nickenig G. Cellular antioxidant effects of atorvastatin in vitro and in vivo. Arterioscler Thromb Vasc Biol. 2002;22:300–5.
-
(2002)
Arterioscler Thromb Vasc Biol
, vol.22
, pp. 300-305
-
-
Wassmann, S.1
Laufs, U.2
Müller, K.3
Konkol, C.4
Ahlbory, K.5
Bäumer, A.T.6
Linz, W.7
Böhm, M.8
Nickenig, G.9
-
29
-
-
84879105232
-
Statins exert the pleiotropic effects through small GTP-binding protein dissociation stimulator upregulation with a resultant Rac1 degradation
-
COI: 1:CAS:528:DC%2BC3sXptlKrtb4%3D, PID: 23640485
-
Tanaka S, Fukumoto Y, Nochioka K, Minami T, Kudo S, Shiba N, Takai Y, Williams CL, Liao JK, Shimokawa H. Statins exert the pleiotropic effects through small GTP-binding protein dissociation stimulator upregulation with a resultant Rac1 degradation. Arterioscler Thromb Vasc Biol. 2013;33:1591–600.
-
(2013)
Arterioscler Thromb Vasc Biol
, vol.33
, pp. 1591-1600
-
-
Tanaka, S.1
Fukumoto, Y.2
Nochioka, K.3
Minami, T.4
Kudo, S.5
Shiba, N.6
Takai, Y.7
Williams, C.L.8
Liao, J.K.9
Shimokawa, H.10
-
30
-
-
0032584177
-
Upregulation of endothelial nitric oxide synthase by HMG CoA reductase inhibitors
-
COI: 1:CAS:528:DyaK1cXisVWmsrY%3D, PID: 9537338
-
Laufs U, La Fata V, Plutzky J, Liao JK. Upregulation of endothelial nitric oxide synthase by HMG CoA reductase inhibitors. Circulation. 1998;97:1129–35.
-
(1998)
Circulation
, vol.97
, pp. 1129-1135
-
-
Laufs, U.1
La Fata, V.2
Plutzky, J.3
Liao, J.K.4
-
31
-
-
0037419766
-
Atorvastatin, administered at the onset of reperfusion, and independent of lipid lowering, protects the myocardium by up-regulating a pro-survival pathway
-
COI: 1:CAS:528:DC%2BD3sXhvFCitbg%3D, PID: 12575984
-
Bell RM, Yellon DM. Atorvastatin, administered at the onset of reperfusion, and independent of lipid lowering, protects the myocardium by up-regulating a pro-survival pathway. J Am Coll Cardiol. 2003;41:508–15.
-
(2003)
J Am Coll Cardiol
, vol.41
, pp. 508-515
-
-
Bell, R.M.1
Yellon, D.M.2
-
32
-
-
0036707882
-
Postischemic acute renal failure is reduced by short-term statin treatment in a rat model
-
COI: 1:CAS:528:DC%2BD38XntlSrur0%3D, PID: 12191973
-
Gueler F, Rong S, Park JK, Fiebeler A, Menne J, Elger M, Mueller DN, Hampich F, Dechend R, Kunter U, Luft FC, Haller H. Postischemic acute renal failure is reduced by short-term statin treatment in a rat model. J Am Soc Nephrol. 2002;13:2288–98.
-
(2002)
J Am Soc Nephrol
, vol.13
, pp. 2288-2298
-
-
Gueler, F.1
Rong, S.2
Park, J.K.3
Fiebeler, A.4
Menne, J.5
Elger, M.6
Mueller, D.N.7
Hampich, F.8
Dechend, R.9
Kunter, U.10
Luft, F.C.11
Haller, H.12
-
33
-
-
0034758721
-
Pravastatin, a 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor, attenuates renal injury in an experimental model of ischemia-reperfusion
-
COI: 1:CAS:528:DC%2BD3MXnslCrt74%3D, PID: 11676559
-
Joyce M, Kelly C, Winter D, Chen G, Leahy A, Bouchier-Hayes D. Pravastatin, a 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor, attenuates renal injury in an experimental model of ischemia-reperfusion. J Surg Res. 2001;101:79–84.
-
(2001)
J Surg Res
, vol.101
, pp. 79-84
-
-
Joyce, M.1
Kelly, C.2
Winter, D.3
Chen, G.4
Leahy, A.5
Bouchier-Hayes, D.6
-
34
-
-
33845649873
-
Single-dose intravenous simvastatin treatment attenuates renal injury in an experimental model of ischemia-reperfusion in the rat
-
PID: 17130671
-
Nešić Z, Todorović Z, Stojanović R, Basta-Jovanović G, Radojević-Škodrić S, Veličković R, Chatterjee PK, Thiemermann C, Prostran M. Single-dose intravenous simvastatin treatment attenuates renal injury in an experimental model of ischemia-reperfusion in the rat. J Pharmacol Sci. 2006;102:413–7.
-
(2006)
J Pharmacol Sci
, vol.102
, pp. 413-417
-
-
Nešić, Z.1
Todorović, Z.2
Stojanović, R.3
Basta-Jovanović, G.4
Radojević-Škodrić, S.5
Veličković, R.6
Chatterjee, P.K.7
Thiemermann, C.8
Prostran, M.9
-
35
-
-
50149115351
-
Acute protective effects of simvastatin in the rat model of renal ischemia-reperfusion injury: it is never too late for the pretreatment
-
PID: 18719319
-
Todorović Z, Nešić Z, Stojanović R, Basta-Jovanović G, Radojević-Škodrić S, Veličković R, Chatterjee PK, Thiemermann C, Prostran M. Acute protective effects of simvastatin in the rat model of renal ischemia-reperfusion injury: it is never too late for the pretreatment. J Pharmacol Sci. 2008;107:465–70.
-
(2008)
J Pharmacol Sci
, vol.107
, pp. 465-470
-
-
Todorović, Z.1
Nešić, Z.2
Stojanović, R.3
Basta-Jovanović, G.4
Radojević-Škodrić, S.5
Veličković, R.6
Chatterjee, P.K.7
Thiemermann, C.8
Prostran, M.9
-
36
-
-
33646519915
-
Simvastatin improves sepsis-induced mortality and acute kidney injury via renal vascular effects
-
COI: 1:CAS:528:DC%2BD28XjvF2ksrg%3D, PID: 16557230
-
Yasuda H, Yuen PST, Hu X, Zhou H, Star RA. Simvastatin improves sepsis-induced mortality and acute kidney injury via renal vascular effects. Kidney Int. 2006;69:1535–42.
-
(2006)
Kidney Int
, vol.69
, pp. 1535-1542
-
-
Yasuda, H.1
Yuen, P.S.T.2
Hu, X.3
Zhou, H.4
Star, R.A.5
-
37
-
-
34247869755
-
Stains attenuate ischemia-reperfusion injury by inducing heme oxygenase-1 in infiltrating macrophages
-
COI: 1:CAS:528:DC%2BD2sXkvFymsLg%3D, PID: 17392159
-
Gueler F, Park JK, Rong S, Kirsch T, Lindschau C, Zheng W, Elger M, Fiebeler A, Fliser D, Luft FC, Haller H. Stains attenuate ischemia-reperfusion injury by inducing heme oxygenase-1 in infiltrating macrophages. Am J Pathol. 2007;170:1192–9.
-
(2007)
Am J Pathol
, vol.170
, pp. 1192-1199
-
-
Gueler, F.1
Park, J.K.2
Rong, S.3
Kirsch, T.4
Lindschau, C.5
Zheng, W.6
Elger, M.7
Fiebeler, A.8
Fliser, D.9
Luft, F.C.10
Haller, H.11
-
38
-
-
84959267840
-
High-dose perioperative atorvastatin and acute kidney injury following cardiac surgery: a randomized clinical trial
-
COI: 1:CAS:528:DC%2BC28XhtlGrt77F, PID: 26906014
-
Billings FT 4th, Hendricks PA, Schildcrout JS, Shi Y, Petracek MR, Byrne JG, Brown NJ. High-dose perioperative atorvastatin and acute kidney injury following cardiac surgery: a randomized clinical trial. JAMA. 2016;315:877–88.
-
(2016)
JAMA
, vol.315
, pp. 877-888
-
-
Billings, F.T.1
Hendricks, P.A.2
Schildcrout, J.S.3
Shi, Y.4
Petracek, M.R.5
Byrne, J.G.6
Brown, N.J.7
-
39
-
-
84968777332
-
Perioperative rosuvastatin in cardiac surgery
-
COI: 1:CAS:528:DC%2BC28XhtlOltLnE, PID: 27144849
-
Zheng Z, Jayaram R, Jiang L, Emberson J, Zhao Y, Li Q, Du J, Guarguagli S, Hill M, Chen Z, Collins R, Casadei B. Perioperative rosuvastatin in cardiac surgery. N Engl J Med. 2016;374:1744–53.
-
(2016)
N Engl J Med
, vol.374
, pp. 1744-1753
-
-
Zheng, Z.1
Jayaram, R.2
Jiang, L.3
Emberson, J.4
Zhao, Y.5
Li, Q.6
Du, J.7
Guarguagli, S.8
Hill, M.9
Chen, Z.10
Collins, R.11
Casadei, B.12
-
40
-
-
84902136264
-
Therapeutic translation in acute kidney injury: the epithelial/endothelial axis
-
COI: 1:CAS:528:DC%2BC2cXpvFaiur4%3D, PID: 24892710
-
Molitoris BA. Therapeutic translation in acute kidney injury: the epithelial/endothelial axis. J Clin Invest. 2014;124:2355–63.
-
(2014)
J Clin Invest
, vol.124
, pp. 2355-2363
-
-
Molitoris, B.A.1
-
41
-
-
17344385356
-
The effect of statins on mRNA levels of genes related to inflammation, coagulation, and vascular constriction in HUVEC
-
COI: 1:CAS:528:DC%2BD38XnsVCkur0%3D, PID: 12226549
-
Morikawa S, Takabe W, Mataki C, Kanke T, Itoh T, Wada Y, Izumi A, Saito Y, Hamakubo T, Kodama T. The effect of statins on mRNA levels of genes related to inflammation, coagulation, and vascular constriction in HUVEC. J Atheroscler Thromb. 2002;9:178–83.
-
(2002)
J Atheroscler Thromb
, vol.9
, pp. 178-183
-
-
Morikawa, S.1
Takabe, W.2
Mataki, C.3
Kanke, T.4
Itoh, T.5
Wada, Y.6
Izumi, A.7
Saito, Y.8
Hamakubo, T.9
Kodama, T.10
-
42
-
-
84878842316
-
Statins protect human endothelial cells from TNF-induced inflammation via ERK5 activation
-
COI: 1:CAS:528:DC%2BC3sXnsVGltLg%3D, PID: 23608189
-
Wu K, Tian S, Zhou H, Wu Y. Statins protect human endothelial cells from TNF-induced inflammation via ERK5 activation. Biochem Pharmacol. 2013;85:1753–60.
-
(2013)
Biochem Pharmacol
, vol.85
, pp. 1753-1760
-
-
Wu, K.1
Tian, S.2
Zhou, H.3
Wu, Y.4
-
43
-
-
78149481592
-
Mammalian Krüppel-like factors in health and diseases
-
COI: 1:CAS:528:DC%2BC3cXhsFSqtbjM, PID: 20959618
-
McConnell BB, Yang VW. Mammalian Krüppel-like factors in health and diseases. Physiol Rev. 2010;90:1337–81.
-
(2010)
Physiol Rev
, vol.90
, pp. 1337-1381
-
-
McConnell, B.B.1
Yang, V.W.2
-
44
-
-
84901505578
-
Role of Krüppel-like factor 4 and its binding proteins in vascular disease
-
PID: 24573018
-
Yoshida T, Hayashi M. Role of Krüppel-like factor 4 and its binding proteins in vascular disease. J Atheroscler Thromb. 2014;21:402–13.
-
(2014)
J Atheroscler Thromb
, vol.21
, pp. 402-413
-
-
Yoshida, T.1
Hayashi, M.2
-
45
-
-
77954231839
-
Smooth and cardiac muscle-selective knock-out of Krüppel-like factor 4 causes postnatal death and growth retardation
-
COI: 1:CAS:528:DC%2BC3cXnvFShsr0%3D, PID: 20439457
-
Yoshida T, Gan Q, Franke AS, Ho R, Zhang J, Chen YE, Hayashi M, Majesky MW, Somlyo AV, Owens GK. Smooth and cardiac muscle-selective knock-out of Krüppel-like factor 4 causes postnatal death and growth retardation. J Biol Chem. 2010;285:21175–84.
-
(2010)
J Biol Chem
, vol.285
, pp. 21175-21184
-
-
Yoshida, T.1
Gan, Q.2
Franke, A.S.3
Ho, R.4
Zhang, J.5
Chen, Y.E.6
Hayashi, M.7
Majesky, M.W.8
Somlyo, A.V.9
Owens, G.K.10
-
46
-
-
0036340041
-
The zinc-finger transcription factor Klf4 is required for terminal differentiation of goblet cells in the colon
-
COI: 1:CAS:528:DC%2BD38XltVyhsb8%3D, PID: 12015290
-
Katz JP, Perreault N, Goldstein BG, Lee CS, Labosky PA, Yang VW, Kaestner KH. The zinc-finger transcription factor Klf4 is required for terminal differentiation of goblet cells in the colon. Development. 2002;129:2619–28.
-
(2002)
Development
, vol.129
, pp. 2619-2628
-
-
Katz, J.P.1
Perreault, N.2
Goldstein, B.G.3
Lee, C.S.4
Labosky, P.A.5
Yang, V.W.6
Kaestner, K.H.7
-
47
-
-
17144401799
-
Loss of Klf4 in mice causes altered proliferation and differentiation and precancerous changes in the adult stomach
-
COI: 1:CAS:528:DC%2BD2MXjvV2qt7o%3D, PID: 15825076
-
Katz JP, Perreault N, Goldstein BG, Actman L, McNally SR, Silberg DG, Furth EE, Kaestner KH. Loss of Klf4 in mice causes altered proliferation and differentiation and precancerous changes in the adult stomach. Gastroenterology. 2005;128:935–45.
-
(2005)
Gastroenterology
, vol.128
, pp. 935-945
-
-
Katz, J.P.1
Perreault, N.2
Goldstein, B.G.3
Actman, L.4
McNally, S.R.5
Silberg, D.G.6
Furth, E.E.7
Kaestner, K.H.8
-
48
-
-
84962826169
-
KLF4 is essential for induction of cellular identity change and acinar-to-ductal reprogramming during early pancreatic carcinogenesis
-
COI: 1:CAS:528:DC%2BC28XksVWitLk%3D, PID: 26977883
-
Wei D, Wang L, Yan Y, Jia Z, Gagea M, Li Z, Zuo X, Kong X, Huang S, Xie K. KLF4 is essential for induction of cellular identity change and acinar-to-ductal reprogramming during early pancreatic carcinogenesis. Cancer Cell. 2016;29:324–38.
-
(2016)
Cancer Cell
, vol.29
, pp. 324-338
-
-
Wei, D.1
Wang, L.2
Yan, Y.3
Jia, Z.4
Gagea, M.5
Li, Z.6
Zuo, X.7
Kong, X.8
Huang, S.9
Xie, K.10
-
49
-
-
77953713216
-
Krüppel-like factor 4 regulates pressure-induced cardiac hypertrophy
-
COI: 1:CAS:528:DC%2BC3cXntlamsbg%3D, PID: 20433848
-
Liao X, Haldar SM, Lu Y, Jeyaraj D, Paruchuri K, Nahori M, Cui Y, Kaestner KH, Jain MK. Krüppel-like factor 4 regulates pressure-induced cardiac hypertrophy. J Mol Cell Cardiol. 2010;49:334–8.
-
(2010)
J Mol Cell Cardiol
, vol.49
, pp. 334-338
-
-
Liao, X.1
Haldar, S.M.2
Lu, Y.3
Jeyaraj, D.4
Paruchuri, K.5
Nahori, M.6
Cui, Y.7
Kaestner, K.H.8
Jain, M.K.9
-
50
-
-
84907203964
-
Kruppel-like factor 4 protein regulates isoproterenol-induced cardiac hypertrophy by modulating myocardin expression and activity
-
COI: 1:CAS:528:DC%2BC2cXhsFOqtrjI, PID: 25100730
-
Yoshida T, Yamashita M, Horimai C, Hayashi M. Kruppel-like factor 4 protein regulates isoproterenol-induced cardiac hypertrophy by modulating myocardin expression and activity. J Biol Chem. 2014;289:26107–18.
-
(2014)
J Biol Chem
, vol.289
, pp. 26107-26118
-
-
Yoshida, T.1
Yamashita, M.2
Horimai, C.3
Hayashi, M.4
-
51
-
-
33747195353
-
Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by deflined factors
-
COI: 1:CAS:528:DC%2BD28Xpt1aktbs%3D, PID: 16904174
-
Takahashi K, Yamanka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by deflined factors. Cell. 2006;126:663–76.
-
(2006)
Cell
, vol.126
, pp. 663-676
-
-
Takahashi, K.1
Yamanka, S.2
-
52
-
-
34250200913
-
Kruppel-like factor 4 regulates endothelial inflammation
-
COI: 1:CAS:528:DC%2BD2sXks1Gns7g%3D, PID: 17339326
-
Hamik A, Lin Z, Kumar A, Balcells M, Sinha S, Katz J, Feinberg MW, Gerszten RE, Edelman ER, Jain MK. Kruppel-like factor 4 regulates endothelial inflammation. J Biol Chem. 2007;282:13769–79.
-
(2007)
J Biol Chem
, vol.282
, pp. 13769-13779
-
-
Hamik, A.1
Lin, Z.2
Kumar, A.3
Balcells, M.4
Sinha, S.5
Katz, J.6
Feinberg, M.W.7
Gerszten, R.E.8
Edelman, E.R.9
Jain, M.K.10
-
53
-
-
48249113711
-
Conditional deletion of Krüppel-like factor 4 delays downregulation of smooth muscle cell differentiation markers but accelerates neointimal formation following vascular injury
-
COI: 1:CAS:528:DC%2BD1cXmvFOhsbg%3D, PID: 18483411
-
Yoshida T, Kaestner KH, Owens GK. Conditional deletion of Krüppel-like factor 4 delays downregulation of smooth muscle cell differentiation markers but accelerates neointimal formation following vascular injury. Circ Res. 2008;102:1548–57.
-
(2008)
Circ Res
, vol.102
, pp. 1548-1557
-
-
Yoshida, T.1
Kaestner, K.H.2
Owens, G.K.3
-
54
-
-
84870542457
-
Endothelial Kruppel-like factor 4 protects against atherothrombosis in mice
-
COI: 1:CAS:528:DC%2BC38XhvVaktL7P, PID: 23160196
-
Zhou G, Hamik A, Nayak L, Tian H, Shi H, Lu Y, Sharma N, Liao X, Hale A, Boerboom L, Feaver RE, Gao H, Desai A, Schmaier A, Gerson SL, Wang Y, Atkins GB, Blackman BR, Simon DI, Jain MK. Endothelial Kruppel-like factor 4 protects against atherothrombosis in mice. J Clin Invest. 2012;122:4727–31.
-
(2012)
J Clin Invest
, vol.122
, pp. 4727-4731
-
-
Zhou, G.1
Hamik, A.2
Nayak, L.3
Tian, H.4
Shi, H.5
Lu, Y.6
Sharma, N.7
Liao, X.8
Hale, A.9
Boerboom, L.10
Feaver, R.E.11
Gao, H.12
Desai, A.13
Schmaier, A.14
Gerson, S.L.15
Wang, Y.16
Atkins, G.B.17
Blackman, B.R.18
Simon, D.I.19
Jain, M.K.20
more..
-
55
-
-
84898611844
-
Deletion of Krüppel-like factor 4 in endothelial and hematopoietic cells enhances neointimal formation following vascular injury
-
PID: 24470523
-
Yoshida T, Yamashita M, Horimai C, Hayashi M. Deletion of Krüppel-like factor 4 in endothelial and hematopoietic cells enhances neointimal formation following vascular injury. J Am Heart Assoc. 2014;3:e000622.
-
(2014)
J Am Heart Assoc
, vol.3
-
-
Yoshida, T.1
Yamashita, M.2
Horimai, C.3
Hayashi, M.4
-
56
-
-
84983786606
-
Endothelial Krüppel-like factor 4 mediates the protective effect of statins against ischemic AKI
-
COI: 1:CAS:528:DC%2BC28XitFSjtL7L, PID: 26471129
-
Yoshida T, Yamashita M, Iwai M, Hayashi M. Endothelial Krüppel-like factor 4 mediates the protective effect of statins against ischemic AKI. J Am Soc Nephrol. 2016;27:1379–88.
-
(2016)
J Am Soc Nephrol
, vol.27
, pp. 1379-1388
-
-
Yoshida, T.1
Yamashita, M.2
Iwai, M.3
Hayashi, M.4
-
57
-
-
79960021457
-
Krüppel-like factor 4 regulates macrophage polarization
-
COI: 1:CAS:528:DC%2BC3MXovVKgu74%3D, PID: 21670502
-
Liao X, Sharma N, Kapadia F, Zhou G, Lu Y, Hong H, Paruchuri K, Mahabeleshwar GH, Dalmas E, Venteclef N, Flask CA, Kim J, Doreian BW, Lu KQ, Kaestner KH, Hamik A, Clément K, Jain MK. Krüppel-like factor 4 regulates macrophage polarization. J Clin Invest. 2011;121:2736–49.
-
(2011)
J Clin Invest
, vol.121
, pp. 2736-2749
-
-
Liao, X.1
Sharma, N.2
Kapadia, F.3
Zhou, G.4
Lu, Y.5
Hong, H.6
Paruchuri, K.7
Mahabeleshwar, G.H.8
Dalmas, E.9
Venteclef, N.10
Flask, C.A.11
Kim, J.12
Doreian, B.W.13
Lu, K.Q.14
Kaestner, K.H.15
Hamik, A.16
Clément, K.17
Jain, M.K.18
-
58
-
-
84870059127
-
−/− mice—brief report
-
COI: 1:CAS:528:DC%2BC38Xhs1GqsbzK, PID: 23065827
-
−/− mice—brief report. Arterioscler Thromb Vasc Biol. 2012;32:2836–8.
-
(2012)
Arterioscler Thromb Vasc Biol
, vol.32
, pp. 2836-2838
-
-
Sharma, N.1
Lu, Y.2
Zhou, G.3
Liao, X.4
Kapil, P.5
Anand, P.6
Mahabeleshwar, G.H.7
Stamler, J.S.8
Jain, M.K.9
-
59
-
-
77956195624
-
Erk5 activation elicits a vasoprotective endothelial phenotype via induction of Krüppel-like factor 4 (KLF4)
-
COI: 1:CAS:528:DC%2BC3cXhtVahtbvF, PID: 20551324
-
Ohnesorge N, Viemann D, Schmidt N, Czymai T, Spiering D, Schmolke M, Ludwig S, Roth J, Goebeler M, Schmidt M. Erk5 activation elicits a vasoprotective endothelial phenotype via induction of Krüppel-like factor 4 (KLF4). J Biol Chem. 2010;285:26199–210.
-
(2010)
J Biol Chem
, vol.285
, pp. 26199-26210
-
-
Ohnesorge, N.1
Viemann, D.2
Schmidt, N.3
Czymai, T.4
Spiering, D.5
Schmolke, M.6
Ludwig, S.7
Roth, J.8
Goebeler, M.9
Schmidt, M.10
-
60
-
-
84902310910
-
Direct evidence for pitavastatin induced chromatin structure change in the KLF4 gene in endothelial cells
-
PID: 24797675
-
Maejima T, Inoue T, Kanki Y, Kohro T, Li G, Ohta Y, Kimura H, Kobayashi M, Taguchi A, Tsutsumi S, Iwanari H, Yamamoto S, Aruga H, Dong S, Stevens JF, Poh HM, Yamamoto K, Kawamura T, Mimura I, Suehiro J, Sugiyama A, Kaneki K, Shibata H, Yoshinaka Y, Doi T, Asanuma A, Tanabe S, Tanaka T, Minami T, Hamakubo T, Sakai J, Nozaki N, Aburatani H, Nangaku M, Ruan X, Tanabe H, Ruan Y, Ihara S, Endo A, Kodama T, Wada Y. Direct evidence for pitavastatin induced chromatin structure change in the KLF4 gene in endothelial cells. PLoS One. 2014;9:e96005.
-
(2014)
PLoS One
, vol.9
-
-
Maejima, T.1
Inoue, T.2
Kanki, Y.3
Kohro, T.4
Li, G.5
Ohta, Y.6
Kimura, H.7
Kobayashi, M.8
Taguchi, A.9
Tsutsumi, S.10
Iwanari, H.11
Yamamoto, S.12
Aruga, H.13
Dong, S.14
Stevens, J.F.15
Poh, H.M.16
Yamamoto, K.17
Kawamura, T.18
Mimura, I.19
Suehiro, J.20
Sugiyama, A.21
Kaneki, K.22
Shibata, H.23
Yoshinaka, Y.24
Doi, T.25
Asanuma, A.26
Tanabe, S.27
Tanaka, T.28
Minami, T.29
Hamakubo, T.30
Sakai, J.31
Nozaki, N.32
Aburatani, H.33
Nangaku, M.34
Ruan, X.35
Tanabe, H.36
Ruan, Y.37
Ihara, S.38
Endo, A.39
Kodama, T.40
Wada, Y.41
more..
|